This report describes the results of the Omani National Drug Policy survey conducted in October 2003. The survey was carried out in eight of the 10 health regions and focused on the Level II core indicators. These indicators support the Level I structure and process indicators by providing specific data about critical pharmaceutical outcomes. The indicators are measured in public health facilities, private pharmacies and in regional distribution points supplying both areas. The main parameters measured relate to access, cost, quality and rational drug use.